Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Baxter
Moodys
Mallinckrodt
McKesson

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Florbetapir f-18 - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for florbetapir f-18 and what is the scope of freedom to operate?

Florbetapir f-18 is the generic ingredient in one branded drug marketed by Avid Radiopharms Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Florbetapir f-18 has forty-eight patent family members in thirty-two countries.

One supplier is listed for this compound.

Summary for florbetapir f-18
International Patents:48
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 3
Clinical Trials: 40
Patent Applications: 7
DailyMed Link:florbetapir f-18 at DailyMed
Recent Clinical Trials for florbetapir f-18

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Neil M Rofsky, MD, MHAPhase 2
Five Eleven Pharma, Inc.Phase 1
National Institute on Aging (NIA)Phase 3

See all florbetapir f-18 clinical trials

Pharmacology for florbetapir f-18
Synonyms for florbetapir f-18
[18F]Florbetapir
18F-AV-45
18F-AV45
18FAV45
4-((1E)-2-(6-{2-(2-(2-(18F)fluoroethoxy)ethoxy)ethoxy}pyridin-3-yl)ethenyl)-N- methylbenzenamine
4-(2-(6-(2-(2-(2-Fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-N-methylbenzamide
4-[(E)-2-[6-(2-{2-[2-(18F)fluoroethoxy]ethoxy}ethoxy)pyridin-3-yl]ethenyl]-N-methylaniline
4-{(E)-2-[6-(2-{2-[2-((18)F)fluoroethoxy]ethoxy}ethoxy)pyridin-3-yl]ethenyl}-N-methylaniline
4-{(E)-2-[6-(2-{2-[2-(18F)fluoroethoxy]ethoxy}ethoxy)pyridin-3-yl]ethenyl}-N-methylaniline
6W15Z5R0RU
956103-76-7
Amyvid
Amyvid (TN)
AV-45
AV-45 compound
Benzenamine, 4-((1E)-2-(6-(2-(2-(2-(fluoro-18F)ethoxy)ethoxy)ethoxy)-3- pyridinyl)ethenyl)-N- methyl-
CHEBI:66880
CHEMBL1774461
D09617
DB09149
DTXSID80241898
Florbetapir
florbetapir (18F)
Florbetapir (18F) [INN]
Florbetapir F 18
Florbetapir F-18 (USAN)
Florbetapir F-18 [USAN:INN]
florbetapir F18
florbetapir-fluorine-18
GTPL7344
Pet AV-45
SCHEMBL14826096
UNII-6W15Z5R0RU
YNDIAUKFXKEXSV-CRYLGTRXSA-N

US Patents and Regulatory Information for florbetapir f-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avid Radiopharms Inc AMYVID florbetapir f-18 SOLUTION;INTRAVENOUS 202008-002 Apr 6, 2012 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Avid Radiopharms Inc AMYVID florbetapir f-18 SOLUTION;INTRAVENOUS 202008-001 Apr 6, 2012 DISCN No No   Start Trial   Start Trial Y Y   Start Trial
Avid Radiopharms Inc AMYVID florbetapir f-18 SOLUTION;INTRAVENOUS 202008-003 Apr 6, 2012 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Avid Radiopharms Inc AMYVID florbetapir f-18 SOLUTION;INTRAVENOUS 202008-003 Apr 6, 2012 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Avid Radiopharms Inc AMYVID florbetapir f-18 SOLUTION;INTRAVENOUS 202008-001 Apr 6, 2012 DISCN No No   Start Trial   Start Trial Y Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for florbetapir f-18

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1999109 92232 Luxembourg   Start Trial PRODUCT NAME: FLORBETAPIR (18 F)
1999109 CA 2013 00035 Denmark   Start Trial
1999109 13C0034 France   Start Trial PRODUCT NAME: FLORBETAPIR (18F); REGISTRATION NO/DATE: EU/1/12/805 20130114
1999109 139 5017-2013 Slovakia   Start Trial PRODUCT NAME: FLORBETAPIR ( 18 F); REGISTRATION NO/DATE: EU/1/12/805 20130114
1999109 2013C/044 Belgium   Start Trial PRODUCT NAME: AMYVID - FLORBETAPIR (18F); AUTHORISATION NUMBER AND DATE: EU/1/12/805 20130114
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
McKinsey
Johnson and Johnson
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.